Published in Antimicrob Agents Chemother on June 01, 1977
Microtiter method for MIC testing with spherule-endospore-phase Coccidioides immitis. J Clin Microbiol (1988) 1.72
Comparative susceptibility of four kinds of pathogenic fungi to amphotericin B and amphotericin B methyl ester. Antimicrob Agents Chemother (1978) 0.91
Traveller's coccidioidomycosis: case report of pulmonary infection diagnosed in Israel. J Clin Microbiol (1992) 0.75
Obfuscation of the activity of antifungal antimicrobics by culture media. J Infect Dis (1972) 7.47
Immunity to coccidioi-domycosis induced in mice by purified spherule, arthrospore, and mycelial vaccines. Trans N Y Acad Sci (1960) 4.83
Miconazole in coccidiodomycosis. II. Therapeutic and pharmacologic studies in man. Am J Med (1976) 3.91
Miconazole in coccidioidomycosis. I. Assays of activity in mice and in vitro. J Infect Dis (1975) 2.99
Amphotericin B serum concentrations during therapy. Appl Microbiol (1970) 2.66
Experience with amphotericin B for the treatment of systemic mycoses. AMA Arch Intern Med (1958) 2.52
In vitro antifungal activity of clotrimazole (Bay b 5097). Infect Immun (1971) 2.48
Coccidioidomycosis and its treatment with amphotericin B. Am J Med (1958) 2.44
Treatment of disseminated mycotic infectioons. A new approach to amphotericin B therapy. Am J Med (1968) 2.18
Some aspects of the absorption, distribution, and excretion of amphotericin B in man. Antibiotic Med Clin Ther (New York) (1958) 2.04
Intravenous and intrathecal miconazole therapy for systemic mycoses. West J Med (1977) 1.57
The use of amphotericin B in the treatment of coccidioidal disease. Am J Med (1959) 1.52
Susceptibility of coccidioides immitis, Candida albicans, and Cryptococcus neoformans to amphotericin B, flucytosine, and clotrimazole. J Infect Dis (1975) 1.50
A therapeutic dilemma. The treatment of disseminated coccidioidomycosis with amphotericin B. Ann Intern Med (1962) 1.25
Immunization of mice with viable Cocidioides immitis. J Immunol (1961) 1.24
Inhibition of growth of Coccidioides immitis on Sabouraud medium containing polymyxin B. J Clin Microbiol (1975) 1.22
Effect of amphotericin B and rifampin against Coccidioides immitis in vitro and in vivo. Antimicrob Agents Chemother (1976) 1.16
Relationship of the in vivo form of Coccidioides immitis to virulence. J Infect Dis (1956) 1.13
Approaches to the physiology of Coccidioides immitis. Ann N Y Acad Sci (1960) 1.06
An evaluation of amphotericin B in vitro and in vivo in mice against Coccidioides immitis and Candida albicans, and preliminary observations concerning the administration of amphotericin B to man. J Invest Dermatol (1957) 1.05
Inhibition of Coccidioides immitis in vitro and enhancement of antiococcidiodial effects of amphotericin B by polymyxin B. Antimicrob Agents Chemother (1975) 1.02
Experience with amphotericin B. Ann N Y Acad Sci (1960) 1.00
Lysozyme-enhanced killing of Candida albicans and Coccidioides immitis by amphoteracin B. Sabouraudia (1974) 0.93
The determination of serum concentrations of amphotericin B in man. Am Rev Tuberc (1958) 0.86
Treatment of murine coccidioidomycosis with polymyxin B. Antimicrob Agents Chemother (1976) 0.78
Development of resistance to amphotericin B in Candida lusitaniae infecting a human. Antimicrob Agents Chemother (1979) 3.79
Epidemiology of coccidioidomycosis. Curr Top Med Mycol (1988) 2.45
Significance of T cells in resistance to experimental murine coccidioidomycosis. Infect Immun (1977) 2.14
The role of bactericidal/permeability-increasing protein as a natural inhibitor of bacterial endotoxin. J Immunol (1992) 1.92
An epidemic of coccidioidomycosis among archeology students in northern California. N Engl J Med (1972) 1.77
Mechanisms of resistance to infection with Coccidioides immitis in mice. Infect Immun (1979) 1.76
Microtiter method for MIC testing with spherule-endospore-phase Coccidioides immitis. J Clin Microbiol (1988) 1.72
Effect of measles immunization on tuberculin hypersensitivity and in vitro lymphocyte reactivity. Int Arch Allergy Appl Immunol (1971) 1.68
Activation of macrophages by lymphokines: enhancement of phagosome-lysosome fusion and killing of Coccidioides immitis. Infect Immun (1983) 1.67
Interaction of azoles with rifampin, phenytoin, and carbamazepine: in vitro and clinical observations. Clin Infect Dis (1992) 1.58
A coccidioidomycosis outbreak following the Northridge, Calif, earthquake. JAMA (1997) 1.54
Evaluation of nikkomycins X and Z in murine models of coccidioidomycosis, histoplasmosis, and blastomycosis. Antimicrob Agents Chemother (1990) 1.54
Safety, pharmacokinetics, and functional activity of human anti-Pseudomonas aeruginosa monoclonal antibodies in septic and nonseptic patients. J Infect Dis (1991) 1.50
Characterization of a soluble protein of Coccidiodes immitis with activity as an immunodiffusion-complement fixation antigen. J Clin Microbiol (1988) 1.49
Comparison of immunoblot analyses of spherule-endospore-phase extracellular protein and mycelial-phase antigen of Coccidioides immitis. Infect Immun (1986) 1.47
Comparison of immunodiffusion techniques with standard complement fixation assay for quantitation of coccidioidal antibodies. J Clin Microbiol (1983) 1.43
Proteinase production by the parasitic cycle of the pathogenic fungus Coccidioides immitis. Infect Immun (1987) 1.40
Comparison and diagnostic value of the coccidioidin heat-stable (HS and tube precipitin) antigens in immunodiffusion. J Clin Microbiol (1985) 1.39
Use of DBA/2N mice in models of systemic candidiasis and pulmonary and systemic aspergillosis. Infect Immun (1990) 1.38
Role of lymphocytes in macrophage-induced killing of Coccidioides immitis in vitro. Infect Immun (1981) 1.38
Characterisation of an antigenically unusual virus responsible for two outbreaks of Newcastle disease in the Republic of Ireland in 1990. Vet Rec (1992) 1.35
Inhibition by lysozyme of growth of the spherule phase of Coccidioides immitis in vitro. Infect Immun (1974) 1.33
Comparative evaluation of commercial Premier EIA and microimmunodiffusion and complement fixation tests for Coccidioides immitis antibodies. J Clin Microbiol (1995) 1.32
Protective activity of an intravenous immune globulin (human) enriched in antibody against lipopolysaccharide antigens of Pseudomonas aeruginosa. Am J Med (1984) 1.31
Tempest from Tehachapi takes toll or Coccidioides conveyed aloft and afar. West J Med (1978) 1.27
Characterization of viruses which represent further distinct serotypes (PMV-8 and PMV-9) of avian paramyxoviruses. Arch Virol (1983) 1.25
The coccidioidal complement fixation and immunodiffusion-complement fixation antigen is a chitinase. Infect Immun (1992) 1.23
Inhibition of growth of Coccidioides immitis on Sabouraud medium containing polymyxin B. J Clin Microbiol (1975) 1.22
Coccidioidomycosis during human immunodeficiency virus infection. A review of 77 patients. Medicine (Baltimore) (1990) 1.19
Comparison of Newcastle disease viruses isolated from cormorants in Canada and the USA in 1975, 1990 and 1992. Can J Vet Res (1996) 1.18
Vasculitic and encephalitic complications associated with Coccidioides immitis infection of the central nervous system in humans: report of 10 cases and review. Clin Infect Dis (1992) 1.18
Protection against lethal murine coccidioidomycosis by a soluble vaccine from spherules. Infect Immun (1998) 1.18
Antigenic diversity and similarities detected in avian paramyxovirus type 1 (Newcastle disease virus) isolates using monoclonal antibodies. Avian Pathol (1997) 1.17
Immunization of mice against coccidioidomycosis with a subcellular vaccine. Infect Immun (1979) 1.16
Effect of amphotericin B and rifampin against Coccidioides immitis in vitro and in vivo. Antimicrob Agents Chemother (1976) 1.16
Isolation and properties of viruses from poultry in Hong Kong which represent a new (sixth) distinct group of avian paramyxoviruses. J Gen Virol (1980) 1.15
Location of neutralizing epitopes on the fusion protein of Newcastle disease virus strain Beaudette C. J Gen Virol (1989) 1.12
Inhibition of chitin synthesis in the cell wall of Coccidioides immitis by polyoxin D. J Bacteriol (1983) 1.11
Coccidioidin delayed hypersensitivity: skin test and in vitro lymphocyte reactivities. J Immunol (1969) 1.10
Purification and amino-terminal sequence analysis of the complement-fixing and precipitin antigens from Coccidioides immitis. J Clin Microbiol (1990) 1.10
Widespread occurrence of Pneumocystis carinii in commercial rat colonies detected using targeted PCR and oral swabs. J Clin Microbiol (2001) 1.09
Endemic coccidioidomycosis in Northern California. An outbreak in the Capay Valley of Yolo County. Calif Med (1969) 1.09
Cutaneous infection in man caused by Fusarium moniliforme. Sabouraudia (1977) 1.08
Immunoaffinity isolation and partial characterization of the Coccidioides immitis antigen detected by the tube precipitin and immunodiffusion-tube precipitin tests. J Clin Microbiol (1989) 1.08
A model of coccidioidal meningoencephalitis and cerebrospinal vasculitis in the rabbit. J Infect Dis (1998) 1.07
Outbreak of coccidioidomycosis in Washington state residents returning from Mexico. Clin Infect Dis (2000) 1.06
Inhibitors of sterol biosynthesis and amphotericin B reduce the viability of pneumocystis carinii f. sp. carinii. Antimicrob Agents Chemother (2000) 1.04
Antibody in cerebrospinal fluid in non-meningitic coccidioidomycosis. Sabouraudia (1972) 1.04
Astrovirus-like particles associated with hepatitis in ducklings. Vet Rec (1984) 1.03
Characterization of Coccidioides immitis isolates by restriction fragment length polymorphisms. J Clin Microbiol (1994) 1.03
The present status of vaccination against coccidioidomycosis in man. Am J Epidemiol (1975) 1.03
Coccidioidomycosis in Northern California. An outbreak among archeology students near Red Bluff. Calif Med (1973) 1.02
Amino-terminal sequence analysis of the Coccidioides immitis chitinase/immunodiffusion-complement fixation protein. Infect Immun (1993) 1.02
Effects of lysozyme and chitinase on the spherules of Coccidioides immitis in vitro. Infect Immun (1973) 1.01
Epidemiological aspects of respiratory mycotic infections. Bacteriol Rev (1967) 1.00
Pathogenicity of PMV-3/parakeet/Netherlands/449/75 for chickens. Avian Pathol (1982) 0.99
Development of vaccines for coccidioidomycosis. Mycopathol Mycol Appl (1970) 0.99
Chronic pulmonary and disseminated paracoccidioidomycosis in mice: quantitation of progression and chronicity. J Med Vet Mycol (1987) 0.98
Ethnic background and the clinical course of coccidioidomycosis. Am Rev Respir Dis (1979) 0.98
Comparative efficacies of terbinafine and fluconazole in treatment of experimental coccidioidal meningitis in a rabbit model. Antimicrob Agents Chemother (2000) 0.98
Comparison of fluconazole and itraconazole in a rabbit model of coccidioidal meningitis. Antimicrob Agents Chemother (2000) 0.97
False-positive IgM serology in coccidioidomycosis. J Clin Microbiol (2010) 0.96
Immunization against Brucella infections. Effects of graded doses of viable attenuated Brucella melitensis in humans. Am J Epidemiol (1966) 0.96
Assessment of the human cellular immune response to T27K, a coccidioidal antigen preparation, by flow cytometry of whole blood. Med Mycol (2001) 0.96
Anti-Pseudomonas aeruginosa activity of an intravenous human IgG preparation in burned mice. J Trauma (1983) 0.95
Spherulin as a complement-fixing antigen in human coccidioidomycosis. Am Rev Respir Dis (1974) 0.95
Coccidioidomycosis and pregnancy. Obstet Gynecol Surv (1993) 0.95
Immunotherapy in recurrent coccidioidomycosis. Cell Immunol (1974) 0.95
Avian infectious bronchitis virus structural polypeptides: effect of different conditions of disruption and comparison of different strains and isolates. Arch Virol (1980) 0.93
Antigenic and genetic characterisation of Newcastle disease viruses isolated from outbreaks in domestic fowl and turkeys in Great Britain during 1997. Vet Rec (1999) 0.93
Experimental induction of anergy to coccidioidin by antigens of Coccidioides immitis. Infect Immun (1973) 0.93
Lysozyme-enhanced killing of Candida albicans and Coccidioides immitis by amphoteracin B. Sabouraudia (1974) 0.93
Coccidioidomycosis in Tulare County, California, 1991: reemergence of an endemic disease. J Med Vet Mycol (1998) 0.92
Impairment of cellular but not humoral immune responses in chronic pulmonary and disseminated paracoccidioidomycosis in mice. Infect Immun (1988) 0.92
Rapid pathotyping of Newcastle disease virus (NDV) using fluorogenic probes in a PCR assay. Vet Microbiol (2001) 0.90
Paramyxovirus type 1 infections of racing pigeons: 1 characterisation of isolated viruses. Vet Rec (1984) 0.90
Monoclonal antibody-mediated protection and neutralization of motility in experimental Proteus mirabilis infection. Infect Immun (1989) 0.89
Pseudomonas hyperimmune globulin passive immunotherapy for pulmonary exacerbations in cystic fibrosis. Pediatr Pulmonol (1990) 0.88
Disseminated coccidioidomycosis in a patient with the acquired immune deficiency syndrome. Diagn Microbiol Infect Dis (1986) 0.88
Treatment of experimental Pseudomonas aeruginosa pneumonia with a human IgM monoclonal antibody. J Infect Dis (1989) 0.87
In vitro hemolysis of autologous erythrocytes caused by immune murine spleen cells and spherules of the fungus Coccidioides immitis. J Immunol (1976) 0.87
Histopathologic response of mice to killed vaccines of Coccidioides immitis. J Invest Dermatol (1967) 0.86
Integrative research review of risk behaviors among adolescents in rural, suburban, and urban areas. J Adolesc Health (1999) 0.86
Comparison of topical administration of clotrimazole through surgically placed versus nonsurgically placed catheters for treatment of nasal aspergillosis in dogs: 60 cases (1990-1996). J Am Vet Med Assoc (1998) 0.86
Effect of pH on the growth and cytopathogenicity of avian infectious bronchitis virus in chick kidney cells. Arch Virol (1975) 0.86
Early acquisition of Pneumocystis carinii in neonatal rats using targeted PCR and oral swabs. J Eukaryot Microbiol (2001) 0.86
Association of ABO blood group and outcome of coccidioidal infection. Sabouraudia (1979) 0.85
Preparation and standardization of antigens of Histoplasma capsulatum and Coccidioides immitis. Mycopathol Mycol Appl (1970) 0.85
Immunologic responsiveness and safety associated with the Coccidioides immitis spherule vaccine in volunteers of white, black, and Filipino ancestry. Am J Epidemiol (1984) 0.84
Antigenic and structural relationships between avian paramyxoviruses isolated from ducks in Hong Kong and Mississippi, U.S.A. J Gen Virol (1979) 0.84
Computed tomographic assessment of noninvasive intranasal infusions in dogs with fungal rhinitis. Vet Surg (1996) 0.84
Further characterisation of a virus associated with turkey rhinotracheitis. Vet Rec (1986) 0.83
Characterization of viruses from doves representing a new serotype of avian paramyxoviruses. Arch Virol (1981) 0.83
Characterisation of avian paramyxoviruses of serotype PMV-3 isolated from commercial turkeys in Great Britain. Avian Pathol (1984) 0.82
Coccidioidomycosis in a bottlenose dolphin. J Wildl Dis (1998) 0.82